Lachlan Hanbury Brown
Stock Analyst at William Blair
(2.56)
# 3,311
Out of 4,683 analysts
135
Total ratings
51.4%
Success rate
1.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lachlan Hanbury Brown
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HROW Harrow | Maintained: Buy | n/a | $39.33 | - | 21 | Aug 20, 2026 | |
| SRZN Surrozen | Initiated Coverage: Buy | $51 | $23.71 | +115.10% | 1 | Aug 20, 2026 | |
| OCUL Ocular Therapeutix | Maintained: Buy | n/a | $10.77 | - | 18 | Aug 17, 2026 | |
| SPRY ARS Pharmaceuticals | Maintained: Buy | n/a | $6.03 | - | 28 | Aug 14, 2026 | |
| TARS Tarsus Pharmaceuticals | Maintained: Buy | n/a | $70.65 | - | 14 | Aug 12, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Maintained: Buy | n/a | $10.28 | - | 6 | Aug 12, 2026 | |
| LENZ LENZ Therapeutics | Maintained: Buy | n/a | $4.78 | - | 20 | Aug 12, 2026 | |
| KLRS Kalaris Therapeutics | Maintained: Buy | n/a | $4.08 | - | 13 | Aug 11, 2026 | |
| VRDN Viridian Therapeutics | Maintained: Buy | n/a | $24.26 | - | 10 | Aug 6, 2026 | |
| SLDB Solid Biosciences | Maintained: Buy | n/a | $9.72 | - | 2 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $11.74 | - | 2 | Mar 16, 2026 |
Harrow
Aug 20, 2026
Maintained: Buy
Price Target: n/a
Current: $39.33
Upside: -
Surrozen
Aug 20, 2026
Initiated Coverage: Buy
Price Target: $51
Current: $23.71
Upside: +115.10%
Ocular Therapeutix
Aug 17, 2026
Maintained: Buy
Price Target: n/a
Current: $10.77
Upside: -
ARS Pharmaceuticals
Aug 14, 2026
Maintained: Buy
Price Target: n/a
Current: $6.03
Upside: -
Tarsus Pharmaceuticals
Aug 12, 2026
Maintained: Buy
Price Target: n/a
Current: $70.65
Upside: -
Eupraxia Pharmaceuticals Inc.
Aug 12, 2026
Maintained: Buy
Price Target: n/a
Current: $10.28
Upside: -
LENZ Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: n/a
Current: $4.78
Upside: -
Kalaris Therapeutics
Aug 11, 2026
Maintained: Buy
Price Target: n/a
Current: $4.08
Upside: -
Viridian Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $24.26
Upside: -
Solid Biosciences
Mar 20, 2026
Maintained: Buy
Price Target: n/a
Current: $9.72
Upside: -
Mar 16, 2026
Maintained: Buy
Price Target: n/a
Current: $11.74
Upside: -